I think biotech stocks (like MRNA for example) are having a savage comeback similar to the post dotcom-boom in the early 2000s

Back in 2000-2005 when biotech stocks ruled for a cycle and every single one you bought was basically a winner, I think the same thing has been forming for the past few months in a world post-AI bump. Biotech seems to becoming a major rhetoric again now with AI advancements and what not. It isn't just Moderna either. If you look across the sector, capital has clearly been flowing back into biotech after years of getting hammered. A lot of these companies spent years trading down after the COVID hype faded. AI is only adding fuel to it by making drug discovery, genomics and personalised medicine much more viable investment themes. Basically, all I'm saying is that it honestly reminds me of how biotech became the next major growth story after the dotcom era.